论文信息 - Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group - 字舞流文

Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group

M. Beckmann | S. Loibl | T. Schuster | M. Untch | J. Huober | C. Jackisch | C. Thomssen | E. Stickeler | H. Eidtmann | G. Minckwitz | H. Lück | I. Schrader | A. Bois | B. Richter | M. Hubalek | V. Heilmann | K. Wollschläger | Ann Stähler